People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Merrimack Pharmaceuticals Inc | — | Pharmaceuticals | Series C | $77.0M | $2.7B | 2011 |
Gordon A. Fehr at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gordon A. Fehr on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| MICHAEL A. PORTER | 1 | 2 |
| William A. Sullivan | 1 | 2 |
| Robert J. Mulroy | 1 | 1 |
| Gary A. Crocker | 1 | 1 |
| Walter A. Lovenberg | 1 | 1 |
| Anthony A. Sinskey | 1 | 1 |
| Sarah A. Nash | 1 | 1 |
| Robert A. Gay | 1 | 1 |
| James A. Dresser | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.